FIELD: chemistry.
SUBSTANCE: described is a method of producing novel intermediate compounds - salts of formula 
or tautomers thereof, where [Kat]n+ denotes an alkali metal cation and n equals 1, compounds themselves and use thereof in valsartan synthesis.
EFFECT: obtaining novel intermediate compounds.
12 cl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMBINATIONS OF ANGIOTENSIN RECEPTOR ANTAGONIST AND NEP INHIBITOR | 2006 |
|
RU2503668C2 |
| PHARMACEUTICAL COMBINATIONS OF ANGIOTENSINE RECEPTOR ANTAGONIST AND NEP INHIBITOR | 2006 |
|
RU2459809C2 |
| VALSARTAN SALTS, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD FOR PREPARING SALTS | 2001 |
|
RU2275363C2 |
| SUBSTITUTED IMIDAZOLES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS AND A PHARMACEUTICAL COMPOSITION | 1991 |
|
RU2099330C1 |
| CYCLIC THIO-SUBSTITUTED DERIVATIVES OF ACYLAMINO ACID AMIDE AND METHOD OF THEIR SYNTHESIS | 1998 |
|
RU2193556C2 |
| ARALKYLSUBSTITUTED IMIDAZOLES SHOWING ANTIHYPERTENSIVE ACTION, METHOD OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION SHOWING INHIBITING ACTIVITY WITH RESPECT TO ANGIOTENSIN II | 1990 |
|
RU2067581C1 |
| APPLICATION OF VALSARTAN OR METABOLITE THEREOF FOR INHIBITION OF THROMBOCYTE AGGREGATION | 2003 |
|
RU2334512C2 |
| METHOD OF VALSARTAN OBTAINMENT | 2003 |
|
RU2348619C2 |
| METHOD OF PREPARING DERIVATIVES OF 3-(TETRAZOL-5-YL)-1-AZAXANTHONE OR THEIR SALTS | 0 |
|
SU858570A3 |
| DERIVATIVES OF IMIDAZOLE, METHODS OF THEIR SYNTHESIS, INTERMEDIATE COMPOUNDS AND PHARMACEUTICAL COMPOSITION BASED ON IMIDAZOLE DERIVATIVES | 1995 |
|
RU2187507C2 |
